Come up with a name for your new list and we'll add to it:
Promentis Pharmaceuticals raised a round of funding on August 16, 2008. Investors include
National Institutes of Health.
Promentis Pharmaceuticals is a pharmaceutical company developing compounds for the treatment of schizophrenia and other central nervous system disorders. Promentis' drug development efforts are focuse…